Jon Cuthbert

Bitpanda and Raiffeisen Bank International AG (WBAG:RBI) have expanded their digital asset partnership across Central and Eastern Europe.

Elixinol Wellness (ASX:EXL) has entered into a binding agreement to acquire supplement platform Vitable for $2.5 million in shares.

President Donald Trump has disclosed two July purchases of Strategy Inc (NASDAQ:MSTR) shares in a financial disclosure released September 22.

Research firm BMI maintained its 2026 global steel price forecast at US$620 per tonne, stating that elevated input costs will keep prices above previous levels.

Paradigm Biopharmaceuticals (ASX:PAR) has missed a key efficacy threshold in its Phase 3 trial for knee osteoarthritis.

AC Immune (NASDAQ:ACIU) reported that all primary endpoints were met at week 100 in Part 1 of its Phase 2 VacSYn trial evaluating ACI-7104 in early Parkinson’s disease.

Roivant (NASDAQ:ROIV) reported topline results from Immunovant’s proof-of-concept trial of IMVT-1402 in cutaneous lupus erythematosus, with the study failing to meet its primary endpoint.

Manchester United (NYSE:MANU) reported record fiscal 2026 revenue of £677.6 million for the year ended June 30, 2026, while returning to operating profit.

Meta Platforms (NASDAQ:META) is expected to unveil new smart glasses at its annual Connect conference, including a camera-free model amid growing privacy concerns.

TXNM Energy (NYSE:TXNM) declared a regular quarterly dividend of $0.4225 per share on its common stock following a board meeting held on September 22, 2026.